ALLIANCEBERNSTEIN L.P. - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 191 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$112,084
+0.2%
21,3900.0%0.00%
Q4 2023$111,870
-66.8%
21,3900.0%0.00%
Q3 2023$337,320
-61.1%
21,390
-52.0%
0.00%
Q2 2023$866,091
-27.3%
44,552
+6.1%
0.00%
-100.0%
Q1 2023$1,191,455
-6.4%
41,997
-3.5%
0.00%0.0%
Q4 2022$1,272,499
+21.8%
43,534
+10.1%
0.00%0.0%
Q3 2022$1,045,000
-41.0%
39,556
-0.8%
0.00%0.0%
Q2 2022$1,771,000
-10.4%
39,860
-0.2%
0.00%0.0%
Q1 2022$1,977,000
-4.7%
39,949
-1.9%
0.00%0.0%
Q4 2021$2,074,000
-8.7%
40,733
+0.0%
0.00%0.0%
Q3 2021$2,271,000
+25.5%
40,722
-3.7%
0.00%0.0%
Q2 2021$1,810,000
+23.5%
42,279
+20.4%
0.00%0.0%
Q1 2021$1,466,000
+10.3%
35,122
+23.1%
0.00%0.0%
Q4 2020$1,329,000
+3.5%
28,532
-5.6%
0.00%0.0%
Q3 2020$1,284,000
-23.5%
30,232
-13.6%
0.00%0.0%
Q2 2020$1,679,000
+4.2%
34,990
-0.1%
0.00%0.0%
Q1 2020$1,612,000
-24.7%
35,040
-1.7%
0.00%0.0%
Q4 2019$2,141,000
+6.5%
35,640
+0.3%
0.00%0.0%
Q3 2019$2,010,000
-4.8%
35,540
-6.3%
0.00%0.0%
Q2 2019$2,112,000
+12.9%
37,940
+2.4%
0.00%0.0%
Q1 2019$1,871,000
+12.8%
37,060
-10.0%
0.00%0.0%
Q4 2018$1,658,000
-45.4%
41,160
-6.1%
0.00%
-50.0%
Q3 2018$3,038,000
-8.3%
43,820
+0.0%
0.00%0.0%
Q2 2018$3,314,000
+247.0%
43,800
+141.7%
0.00%
+100.0%
Q1 2018$955,000
-44.3%
18,118
-43.6%
0.00%0.0%
Q4 2017$1,715,000
+0.9%
32,110
+12.6%
0.00%0.0%
Q3 2017$1,700,000
-27.6%
28,510
-4.2%
0.00%
-50.0%
Q2 2017$2,349,000
+95.3%
29,770
+105.3%
0.00%
+100.0%
Q1 2017$1,203,000
-2.8%
14,500
-7.1%
0.00%0.0%
Q4 2016$1,238,000
+13.4%
15,6000.0%0.00%0.0%
Q3 2016$1,092,000
+80.5%
15,6000.0%0.00%0.0%
Q2 2016$605,000
-4.3%
15,6000.0%0.00%0.0%
Q1 2016$632,000
-53.4%
15,600
+2.0%
0.00%0.0%
Q4 2015$1,357,000
+17.0%
15,300
-2.4%
0.00%0.0%
Q3 2015$1,160,000
-8.7%
15,670
-0.2%
0.00%0.0%
Q2 2015$1,270,00015,7000.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Park West Asset Management LLC 636,538$27,040,0001.05%
ARMISTICE CAPITAL, LLC 672,000$28,547,0001.04%
Smith, Graham & Co., Investment Advisors, LP 187,798$7,978,0000.91%
TANG CAPITAL MANAGEMENT LLC 62,262$2,645,0000.48%
Capital Impact Advisors, LLC 35,815$1,521,0000.45%
Matarin Capital Management, LLC 47,508$2,018,0000.42%
GLOBEFLEX CAPITAL L P 33,550$1,425,0000.38%
CHARTWELL INVESTMENT PARTNERS, LLC 198,169$8,418,0000.31%
BRANDES INVESTMENT PARTNERS, LP 154,924$6,582,0000.23%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 278$12,0000.22%
View complete list of EAGLE PHARMACEUTICALS INC shareholders